Franklin Genomic Advancements ETF
HELX
5 hedge funds and large institutions have $1.92M invested in Franklin Genomic Advancements ETF in 2020 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 2 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
93% more capital invested
Capital invested by funds: $991K → $1.92M (+$925K)
15.02% more ownership
Funds ownership: 28.24% → 43.26% (+15%)
0% more funds holding
Funds holding: 5 → 5 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$734K |
| 2 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
+$262K |
| 3 |
Osaic Holdings
Scottsdale,
Arizona
|
+$22.1K |
| 4 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
+$7.09K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
-$351K |
| 2 |
CSPIA
Cary Street Partners Investment Advisory
Richmond,
Virginia
|
-$18K |
| 3 |
BFEC
Benjamin F. Edwards & Company
St. Louis,
Missouri
|
-$8.88K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Jane Street
New York
| $1.15M | +$734K | +18,426 | +245% |
|
|
2
Cambridge Investment Research Advisors
Fairfield,
Iowa
| $291K | +$262K | +6,580 | New |
|
|
3
Commonwealth Equity Services
Waltham,
Massachusetts
| $270K | +$7.09K | +178 | +3% |
|
|
BFEC
4
Benjamin F. Edwards & Company
St. Louis,
Missouri
| $181K | -$8.88K | -223 | -5% |
|
|
5
Osaic Holdings
Scottsdale,
Arizona
| $25K | +$22.1K | +555 | New |
|
|
6
Franklin Resources
San Mateo,
California
| – | -$351K | -10,000 | Closed |
|
|
CSPIA
7
Cary Street Partners Investment Advisory
Richmond,
Virginia
| – | -$18K | -500 | Closed |
|
HELX Hedge Fund Activity: Q4 2020 in Review
5 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Franklin Genomic Advancements ETF (HELX) for Q4 2020, worth a combined $1.92M — up 93% from $991K a quarter earlier.
Fund positioning in HELX was balanced in Q4 2020: 2 funds opened new positions, 2 closed out, 2 added to existing stakes and 1 trimmed.
The largest buyer was Jane Street, adding an estimated $734K. The largest seller was Franklin Resources, exiting entirely with an estimated $351K sold.
- 5 institutional investors held Franklin Genomic Advancements ETF (HELX) as of Q4 2020, unchanged from Q3 2020.
- Funds reported $1.92M of Franklin Genomic Advancements ETF stock for Q4 2020, up 93% quarter-over-quarter.
- 2 funds opened new Franklin Genomic Advancements ETF positions in Q4 2020 and 2 closed out, a net change of 0 holders.
- The largest Franklin Genomic Advancements ETF buyer in Q4 2020 was Jane Street, an estimated $734K added.
- The largest Franklin Genomic Advancements ETF seller in Q4 2020 was Franklin Resources, an estimated $351K sold.
Based on aggregated 13F filings for Q4 2020.